Profile data is unavailable for this security.
About the company
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
- Revenue in GBP (TTM)4.53m
- Net income in GBP-3.33m
- Incorporated1993
- Employees36.00
- LocationProteome Sciences PLCCoveham House, Downside Bridge RoadADDLESTONE KT11 3EPUnited KingdomGBR
- Phone+44 207 043 2116
- Fax+44 203 637 7516
- Websitehttps://www.proteomics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Image Scan Holdings Plc | 1.62m | -288.02k | 1.98m | 13.00 | -- | 1.39 | -- | 1.23 | -0.0021 | -0.0021 | 0.0118 | 0.0105 | 0.6459 | 1.75 | 2.43 | -- | -11.50 | 0.0905 | -17.47 | 0.1358 | 58.50 | 52.65 | -17.80 | 0.0917 | 1.85 | -- | 0.0616 | 0.00 | -43.45 | -14.23 | -239.13 | -- | 34.92 | -- |
| Genincode PLC | 2.91m | -4.97m | 3.30m | 36.00 | -- | 1.24 | -- | 1.13 | -0.0232 | -0.0232 | 0.0137 | 0.0093 | 0.6562 | 15.74 | 2.87 | 80,944.45 | -111.87 | -- | -164.53 | -- | 53.02 | -- | -170.49 | -- | 2.73 | -10.96 | 0.0669 | -- | 25.05 | -- | 36.80 | -- | -- | -- |
| Surgical Innovations Group Plc | 11.92m | -1.44m | 4.20m | 88.00 | -- | 0.4903 | -- | 0.3523 | -0.0015 | -0.0015 | 0.0128 | 0.0092 | 0.9314 | 2.91 | 4.72 | 135,397.70 | -11.22 | -7.76 | -14.17 | -9.60 | 27.89 | 29.97 | -12.04 | -11.66 | 0.9524 | 8.46 | 0.0987 | -- | -0.5743 | 2.16 | -281.73 | -- | -8.28 | -- |
| Cambridge Nutritional Sciences PLC | 8.06m | 1.37m | 4.76m | 84.00 | 3.50 | 0.4305 | 2.38 | 0.5905 | 0.0057 | 0.0057 | 0.0338 | 0.0465 | 0.6153 | 3.59 | 3.57 | 95,940.48 | 10.42 | -3.22 | 11.69 | -3.67 | 66.44 | 58.85 | 16.94 | -7.21 | 3.79 | -- | 0.021 | -- | -14.77 | -3.23 | 577.44 | -- | -29.24 | -- |
| Feedback plc | 885.62k | -7.32m | 4.89m | 28.00 | -- | 0.7925 | -- | 5.52 | -0.2618 | -0.2618 | 0.0309 | 0.1407 | 0.1174 | -- | 9.83 | 31,629.29 | -96.97 | -38.54 | -105.98 | -41.65 | 87.92 | 90.05 | -826.25 | -435.27 | -- | -- | 0.00 | -- | -25.05 | 14.50 | -121.85 | -- | -1.14 | -- |
| Proteome Sciences plc | 4.53m | -3.33m | 6.21m | 36.00 | -- | -- | -- | 1.37 | -0.0113 | -0.0113 | 0.0153 | -0.0291 | 0.5087 | 5.92 | 5.75 | 125,750.00 | -37.44 | -8.02 | -- | -- | 17.43 | 45.80 | -73.60 | -15.07 | 0.0774 | -2.51 | 2.26 | -- | -2.80 | 0.9731 | -39.42 | -- | 31.03 | -- |
| Rua Life Sciences PLC | 5.17m | -850.00k | 9.00m | 33.00 | -- | 1.26 | -- | 1.74 | -0.0137 | -0.0137 | 0.0832 | 0.1151 | 0.5459 | 1.18 | 6.23 | -- | -9.18 | -- | -10.42 | -- | 77.10 | -- | -16.82 | -- | 3.87 | -- | 0.0995 | -- | -- | -- | -- | -- | -- | -- |
| Verici DX PLC | 1.41m | -5.60m | 10.90m | 15.00 | -- | 0.9582 | -- | 7.76 | -0.0231 | -0.0231 | 0.0058 | 0.0075 | 0.2298 | -- | 1.67 | 78,093.98 | -91.48 | -- | -119.40 | -- | 81.60 | -- | -398.12 | -- | -- | -- | 0.102 | -- | 229.62 | -- | 32.75 | -- | -- | -- |
| Genedrive PLC | 954.00k | -5.23m | 11.84m | 43.00 | -- | 5.00 | -- | 12.41 | -0.0093 | -0.0093 | 0.0017 | 0.0023 | 0.1984 | -- | 1.80 | 22,186.05 | -108.81 | -77.52 | -153.92 | -106.30 | -- | -- | -548.32 | -1,016.12 | 1.64 | -- | 0.00 | -- | 90.42 | -2.07 | 26.06 | -- | -10.48 | -- |
| Cellbxhealth PLC | 2.62m | -15.78m | 11.96m | 119.00 | -- | 0.2897 | -- | 4.56 | -0.0489 | -0.0489 | 0.0081 | 0.0362 | 0.1028 | 0.5939 | 1.46 | 22,050.42 | -61.80 | -41.90 | -72.78 | -46.81 | 62.27 | 18.55 | -601.37 | -1,051.13 | 2.63 | -470.57 | 0.2387 | -- | 30.92 | -- | 29.34 | -- | -- | -- |
| Abingdon Health PLC | 8.43m | -3.42m | 15.06m | 121.00 | -- | 2.19 | -- | 1.79 | -0.0176 | -0.0176 | 0.0435 | 0.0274 | 1.17 | 9.71 | 3.87 | 69,661.16 | -47.42 | -54.04 | -70.70 | -85.91 | 44.32 | 30.37 | -40.51 | -110.07 | 1.58 | -- | 0.1625 | -- | 37.39 | 9.99 | -168.69 | -- | -26.92 | -- |
| Inspiration Healthcare Group PLC | 45.20m | -11.44m | 15.24m | 214.00 | -- | 0.9312 | -- | 0.3372 | -0.1275 | -0.1275 | 0.5038 | 0.1826 | 1.03 | 2.00 | 5.91 | 211,215.00 | -25.96 | -6.05 | -33.03 | -7.45 | 44.39 | 46.62 | -25.32 | -7.01 | 1.11 | 2.42 | 0.441 | -- | 1.65 | 16.56 | -148.04 | -- | 39.05 | -- |
Data as of Feb 09 2026. Currency figures normalised to Proteome Sciences PLC's reporting currency: UK Pound GBX
39.25%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Vulpes Investment Management Pte Ltd.as of 02 Feb 2026 | 84.93m | 28.77% |
| Hargreaves Lansdown Fund Managers Ltd.as of 01 Dec 2025 | 19.06m | 6.46% |
| Rathbones Investment Management Ltd.as of 01 Dec 2025 | 2.90m | 0.98% |
| IG Markets Ltd.as of 01 Dec 2025 | 2.62m | 0.89% |
| Rowan Dartington & Co. Ltd. (Broker)as of 01 Dec 2025 | 2.36m | 0.80% |
| James Brearley & Sons Ltd.as of 01 Dec 2025 | 2.31m | 0.78% |
| J. M. Finn & Co. Ltd.as of 01 Dec 2025 | 638.00k | 0.22% |
| iDealing.com Ltd.as of 01 Dec 2025 | 444.00k | 0.15% |
| Charles Schwab Investment Management, Inc.as of 01 Dec 2025 | 295.00k | 0.10% |
| HSBC Global Asset Management (UK) Ltd.as of 01 Dec 2025 | 294.00k | 0.10% |
More ▼
Data from 31 Mar 2025 - 04 Feb 2026Source: FactSet Research Systems Inc.
